Loading clinical trials...
Loading clinical trials...
A Phase I/II Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Subjects With Chronic Refractory Myocardial Ischemia
Conditions
Interventions
VM202
Locations
2
United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Minneapolis Heart Institute Foundation/ Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
Start Date
March 1, 2015
Primary Completion Date
July 1, 2015
Completion Date
January 1, 2016
Last Updated
September 25, 2025
NCT06535568
NCT05865600
NCT05846893
NCT06255769
NCT05248165
NCT05584280
Lead Sponsor
Helixmith Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions